NCT00861692View on ClinicalTrials.gov

Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Heparin-induced Thrombocytopenia Type II
Interventions
DRUG

argatroban

Trial Locations (1)

Unknown

Saint-Etienne

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY